Company: FVN
Filing Date: 2025-01-07
Form Type: DRS/A
Source: 0001829126-25-000092
Chunk: 5

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-01-07
Form: DRS/A
Chunk 5
---
2.15 per Future Vision Ordinary Share held by Future Vision’s Public Shareholders.

Additionally, as of September 30, 2024, a total of $5,667 of service fees have been accrued by Future Vision for services rendered by the Sponsor pursuant to an administrative services agreement between Future Vision and Sponsor.

Finally, if the Sponsor were to loan any amount(s) to Future Vision and/or incur any fees or out-of-pocket expenses on Future Vision’s behalf, the total sum of such loans, fees and out-of-pocket expenses would be repayable on or after the closing of the proposed Business Combination and constitute Sponsor compensation. If any such amounts were loaned or incurred and Future Vision failed to complete an initial business combination before its deadline pursuant to Future Vision’s Amended and Restated Memorandum and Articles of Association, as may be amended to extend such date, such amounts would be forfeited. As of the date of this proxy statement/prospectus, there are no amounts outstanding under any loans payable to the Sponsor and no fees due or out-of-pocket expenses to be repaid by Future Vision to the Sponsor.

Given the Sponsor’s holdings, as of the consummation of the proposed Business Combination, Sponsor will own 1,766,400 New VIWO ordinary shares, comprised of the 1,437,500 Future Vision ordinary shares it currently owns and 29,900 New VIWO ordinary shares to be received in connection with the conversion of its private rights. The New VIWO ordinary shares to be owned by the Sponsor following the proposed Business Combination will be identical to the New VIWO ordinary shares to be held by Future Vision’s public shareholders in every respect. Because only the 29,900 New VIWO ordinary shares to be issued in connection with the conversion of the private rights r held by the Sponsor will be new issuances, only those securities could result in additional material dilution to Future Vision’s public shareholders, and because the public shareholders will also be issued New VIWO ordinary shares in respect of their Future Vision rights, in the same proportion to the Sponsor or greater than that of the Sponsor, since the Future Vision public shareholders who redeem their Future Vision ordinary shares will still receive New VIWO ordinary shares in respect of the Future Vision public rights from their public units, the issuance to the Sponsor of New VIWO ordinary shares in respect of its Future Vision rights could reasonably be seen as not causing any additional substantial dilution to the public shareholders.

This proxy statement/prospectus discusses in more detail such conflicts of interests, including items